MORRISVILLE, N.C.--(BUSINESS WIRE)--Oxygen Biotherapeutics, Inc. (NASDAQ:OXBT) today announced that the Company plans to report third quarter fiscal year 2012 financial results on Form 10-Q on Thursday, March 15, 2012. Oxygen’s President & Chief Financial Officer, Michael Jebsen, will host a conference call and live webcast to discuss the results on Friday, March 16, 2012, at 11 a.m. EDT.
